Bioprocess scale-up: quest for the parameters to be used as criterion to move from microreactors to lab-scale

被引:84
|
作者
Marques, Marco P. C. [1 ]
Cabral, Joaquim M. S. [1 ]
Fernandes, Pedro [1 ]
机构
[1] Inst Super Tecn, IBB Inst Biotechnol & Bioengn, Ctr Biol & Chem Engn, P-1049001 Lisbon, Portugal
关键词
scale-up; small-scale reactors; k(L)a; volumetric power consumption; fermentation; bioconversion; LIQUID MASS-TRANSFER; OXYGEN-TRANSFER RATE; POWER INPUT MEASUREMENTS; ROTARY SHAKING MACHINES; STIRRED-TANK REACTORS; TRANSFER COEFFICIENT; MICROTITER PLATES; PROTEIN EXPRESSION; SULFITE OXIDATION; ESCHERICHIA-COLI;
D O I
10.1002/jctb.2387
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Advances in high-throughput process development and optimization involve the rational use of miniaturized stirred bioreactors, instrumented shaken flasks and microtiter plates. As expected, each one provides different levels of control and monitoring, requiring a compromise between data quantity and quality. Despite recent advances, traditional shaken flasks with nominal volumes below 250 mL and microtiter plates are still widely used to assemble wide arrays of biotransformation/bioconversion data, because of their simplicity and low cost. These tools are key assets for faster process development and optimization, provided data are representative. Nonetheless, the design, development and implementation of bioprocesses can present variations depending on intrinsic characteristics of the overall process. For each particular process, an adequate and comprehensive approach has to be established, which includes pinpointing key issues required to ensure proper scale-up. Recently, focus has been given to engineering characterization of systems in terms of mass transfer and hydrodynamics (through gaining insight into parameters such as k(L)a and P/V at shaken and microreactor scale), due to the widespread use of small-scale reactors in the early developmental stages of bioconversion/biotransfomation processes. Within this review, engineering parameters used as criteria for scaling-up fermentation/bioconversion processes are discussed. Particular focus is on the feasibility of the application of such parameters to small-scale devices and concomitant use for scale-up. Illustrative case studies are presented. (c) 2010 Society of Chemical Industry
引用
收藏
页码:1184 / 1198
页数:15
相关论文
共 50 条
  • [1] Fermentation odor and bioprocess scale-up
    T. R˘ezanka
    J. Votruba
    Bioprocess Engineering, 1998, 19 : 159 - 160
  • [2] Advances and Practices of Bioprocess Scale-up
    Xia, Jianye
    Wang, Guan
    Lin, Jihan
    Wang, Yonghong
    Chu, Ju
    Zhuang, Yingping
    Zhang, Siliang
    BIOREACTOR ENGINEERING RESEARCH AND INDUSTRIAL APPLICATIONS II, 2016, 152 : 137 - 151
  • [3] Fermentation odor and bioprocess scale-up
    Rezanka, T
    Votruba, J
    BIOPROCESS ENGINEERING, 1998, 19 (02) : 159 - 160
  • [4] Getting good scale-up performance - Transferring the scale-up process from the lab to the plant
    Tatterson, G
    CHEMICAL PROCESSING, 2000, 63 (10): : 18 - 18
  • [5] Industrial design, scale-up, and use of microreactors
    Roberge, Dominique M.
    Gottsponer, Michael
    Eyholzer, Markus
    Kockmann, Norbert
    CHIMICA OGGI-CHEMISTRY TODAY, 2009, 27 (04) : 8 - 11
  • [6] Twelve tips for smooth bioprocess scale-up
    De Palma, A
    GENETIC ENGINEERING NEWS, 2004, 24 (14): : 51 - +
  • [7] Making Bioprocess Scale-Up More Robust
    DePalma, Angelo
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2009, 29 (14): : 44 - +
  • [8] Fast Scale-Up Using Microreactors: Pyrrole Synthesis from Micro to Production Scale
    Nieuwland, Pieter J.
    Segers, Ruth
    Koch, Kaspar
    van Hest, Jan C. M.
    Rutjes, Floris P. J. T.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (04) : 783 - 787
  • [9] BIOPROCESS SCALE-UP - REGULATORY CONCERNS AND ISSUES
    HILL, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 166 - BIOT
  • [10] Bioprocess Scale-Up: Getting Smarter, Sooner
    Shanley, Agnes
    BIOPHARM INTERNATIONAL, 2020, 33 (11) : 54 - 56